Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thymoquinone for oral potentially malignant lesions
NCT03208790Phase 2Completed
- Sponsor
- Cairo University
- Start
- Sep 2017
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of thymoquinone in Oral potentially malignant disorders (OPMD), sponsored by Cairo University. Started Sep 2017; status: completed.
02
Drugs
thymoquinone
03
Conditions
Oral potentially malignant disorders (OPMD)
Beyond the preview
Go deeper on NCT03208790.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03208790.